TUBA1B and cancer: The effect of lidoflazine on reducing cancer cell aggressiveness, which was demonstrated in U-87 MG cells, was also confirmed in RR cells via a transwell assay, and the same results were obtained in 3D culture alpha-tubulin staining (Fig. 6g, h).